Emerging Signals Modernization Act of 2022
Sponsored By: Representative Guthrie, Brett [R-KY-2]
Unknown
Summary
Emerging Signals Modernization Act of 2022 This bill establishes certain requirements relating to the Food and Drug Administration's (FDA's) public notices on the potential new risks of approved medical devices (i.e., emerging signals), including with respect to the standards of evidence needed for such notices. The FDA must update its current guidance on emerging signals to align with the bill's requirements.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Guthrie, Brett [R-KY-2]
KY • R
Cosponsors
Rep. Moulton, Seth [D-MA-6]
MA • D
Sponsored 5/3/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov